Kallab S, Bassil N, Esposito L, Cardeau-Desangles I, Rostaing L, Kamar N
Department of Nephrology, Dialysis and Organ Transplantation, INSERM U858, CHU Rangueil, Toulouse, France.
Transplant Proc. 2010 Apr;42(3):782-4. doi: 10.1016/j.transproceed.2010.02.031.
Preemptive kidney transplantation is the treatment of choice for end-stage renal disease. Compared with nonpreemptive transplantation, preemptive transplantation is significantly associated with improved kidney allograft survival in recipients of either cadaver or living-donor transplants. This seems to be related to better patient survival. It can be proposed to all patients, but still needs to be evaluated for repeat transplantation. The main barriers are organ-allocation policies and late referral of patients to transplantation centers.
择期肾移植是终末期肾病的首选治疗方法。与非择期移植相比,择期移植与尸体供肾或活体供肾移植受者的肾移植存活率显著提高相关。这似乎与更好的患者生存率有关。可以向所有患者推荐,但仍需对再次移植进行评估。主要障碍是器官分配政策和患者转诊至移植中心较晚。